Henry Fung, MD, FACP, FRCPE

Henry Chi Hang Fung, MD, FRCPE
(4.7/5.0)
50 Patient Satisfaction Ratings
Request an Appointment

Chair, Department of Bone Marrow Transplant and Cellular Therapies

NCCN, Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrom's Macroglobulinemia Panel

 

Specialties

Key Awards

Philadelphia Magazine Top Docs 2022
Hematology

Language(s) Other than English

  • Cantonese

Treatment Philosophy

Cancer treatment and bone marrow transplant represent a journey for my patients and their families, and it’s my sincere privilege to be a part of this experience. I consider us all to be critical members of a cohesive team in making the right decisions to meet my patients’ treatment goals while maintaining quality of life.

Follow on Twitter: @henrychihangfu1

Educational Background

  • Fellow, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, Hong Kong
  • Clinical Fellow, Hematology, Vancouver Hospital and Health Science Center, British Columbia Cancer Control Agency, University of British Columbia, Canada, 1992-1994 
  • Resident, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, 1991-1992
  • Resident, Internal Medicine, Queen Mary Hospital, Hong Kong University, 1988-1991 
  • MBChB, Medicine, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, 1987

Certifications

  • FRCPE, awarded by Royal College of Physicians, Edinburgh, 2001
  • MRCP (UK), awarded by Royal College of  Physicians, United Kingdom 1991

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Multiple Myeloma/Systemic Light Chain Committee
    • Amyloidosis/Waldenström's Macroglobulinemia Panel
  • American College of Physicians
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Blood and Marrow Transplantation
  • Royal College of Physicians, Edinburgh, United Kingdom

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2018-20
  • Best Doctors in America® , 2019-2020, Medical Oncology and Hematology
  • America’s Top Doctors®, 2014-17
  • Fellow, American College of Physicians, 2014

Judith Bernstein

  • Breast Cancer
  • Lung Cancer
  • Lymphoma
  • Skin Cancer
  • Thyroid Cancer

As a person who has been diagnosed and treated for various types of cancer, I can say with certainty:  Run, don’t walk, to Fox Chase Cancer Center. I have given this piece of advice more times than I can count because I know that where you begin your cancer treatment really does matter.

VIEW PATIENT STORY

Research Interests

  • Allogeneic stem cell transplantation using alternative donors
  • Treatment and stem cell transplantation for multiple myeloma, lymphoma and leukemias, myelodysplasia, myeloproliferative disease and myelofibrosis

Selected Publications

Syed A. Abutalib, Kieron Dunleavy & Henry C. Fung: Primary Mediastinal B Cell Lymphoma. In Clinical Oncology (In Press).

Henry C Fung, Philip Pancari and Patricia Kropf. Primary Central Nervous System Lymphoma. In Clinical Manual of Blood & Marrow Hematopoietic Cell Transplantation. Edited by Dr. Syed A. Abutalib & Dr. Parameswaran Hari (In Press).

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.: A Goy, M Berger, P Ford, T Feldman, A Mato, C Bejot and Henry C Fung - Leukemia & lymphoma, 2014/12. PubMed

Gastrointestinal Side Effects and Adequacy of Enteral Intake in Hematopoietic Stem Cell Transplant Patients: M Walrath, C Bacon, S Foley, HC Fung - Nutrition in Clinical Practice, 2014/9. PubMed

Anger, provider responses, and pain: Prospective analysis of stem cell transplant patients: JI Gerhart, V Sanchez Varela, JW Burns, SE Hobfoll, HC Fung; Health Psychology 34 (3), 197. PubMed

Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients: SE Hobfoll, JI Gerhart, AK Zalta, K Wells, J Maciejewski and Henry C Fung- Psycho‐Oncology, 2015.   PubMed

Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day+ 5 Versus Day+ 10 Post Autologous Hematopoietic Stem Cell Transplant: LM DiGrazia, M Janusek, K Schultz, L Geswein, HC Fung; Journal of Oncology Pharmacy Practice (in press).

Peksa GD, Schultz K, Fung HC: Dosing Algorithm for Concomitant Administration of Sirolimus, Tacrolimus, and an Azole After Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Oncology Pharmacy Practice.  2014 June 17: pii:1078155214539625. [Epub ahead of print]. PubMed

Christopherson KW 2nd, Frank R, Jagan S, Paganessi LA, Rizman A, Gezer S, Gregory SA, Fung HC: CD26 Protease Inhibition Improves Functional Response of Un-fractionated Mobilized Peripheral Blood Mononuclear Cells to CXCL12/SDF-1. Exp Hematol 2012 Nov;40(11):945-52.doi:10.1016/j.exphem.2012.07.009. Epub 2012 Jul 27. PubMed

Tuncer HH, Gregory SA, Fung HC: High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapse after Allo-SCT in Multiple Myeloma: A Case Report. Bone Marrow Transplant Oct 2010. PubMed

 Krishnan A, Nademanee A, Fung HC, Raubitschek AA, Molina A, Yamauchi D, Rodriguez R, Spielberger RT, Falk P, Palmer JM, Forman SJ: Phase II trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients with Non-Hodgkin’s Lymphoma. Journal of clinical Oncology 2008 Jan 1;26(1):90-5. Epub 2007 Nov 19. PubMed

Fung HC, Stif P, Schriber J, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Smith D, Ivers, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nademanee A:. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma. Biol Blood Marrow Transplant 2007 May;13(5):594-600. Epub 2007 Mar 23. PubMed

Sahebi F, Spielberger R, Kogut NM, Fung HC, et al.:  Maintenance Thalidomide Following Single Cycle Autologous Peripheral Blood Stem Cell Transplant in Patients with Multiple Myeloma. Bone Marrow Transplantation 2006 May;37(9):825-9. PubMed

Henry C Fung MBchB, FRCPE, Sunita Nathan MD, John J Maciejewski MD, PhD: Induction Chemotherapy Before Autologous Stem Cell Transplantation for Patients with Symptomatic Plasma Cell Myeloma----does it matter? Clinical Pharmacology: Advances and Applications (2010).  PubMed

A.M. Jimenez, Henry C Fung and Kent Chistopherson II: Strategies for Improving Transplant Efficiency in the Context of Cellular Therapeutics.  Transfusion 2011 Nov; 51 Suppl 4: 125S-137S.  doi: 10.1111/j. 1537-2995.2001.03375.x.   PubMed

50 patient satisfaction reviews

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

Overall Rating

4.7 / 5.0

Ratings Breakdown

4.7
Gives easy to understand instruction
4.6
Explains in a way you understand
4.6
Listens carefully to you
4.8
Shows respect for what you say
4.6
Spends enough time with you

6 patient comments

  • 5.0
    March 11, 2022

    Never a bad experience. They are on the ball and know what they are doing.

  • 5.0
    December 10, 2021

    Everybody at Fox Chase are aces. Top notch, friendly and caring.

  • 5.0
    November 15, 2021

    All Fox Chase employees provided excellent service to me.

  • 5.0
    July 24, 2021

    Dr. Fong is the best provider I have had the privilege to receive healthcare from. He is personal, knowledgeable with the best bedside manner.

  • 5.0
    July 7, 2021

    Henry Fung MD is THE BEST!!

  • 3.5
    February 22, 2021

    A good experience.